http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200135270-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e5ad8562c578b061df7a2c3aee9d0e24
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5011
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57434
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
filingDate 2020-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d372616d51a584cb64f6d7b2dab022c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08ab4e87d28fb460973b403fdf3349f8
publicationDate 2020-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20200135270-A
titleOfInvention Composition for enhancing sensibility for anti-cancer drug of prostate cancer and use of thereof
abstract It relates to a composition for enhancing the susceptibility of prostate cancer to an anticancer agent, which can overcome the resistance of cancer cells to a target anticancer agent, and can increase the sensitivity of the anticancer agent to cancer cells, as well as use it in combination with a conventional target anticancer agent. By administration, the therapeutic effect of prostate cancer can be improved.
priorityDate 2020-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56069
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403567
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO94811
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3875052
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCE2R027
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID40904
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590905
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID461669
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID41183
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID7113
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID832098
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID35199
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100682528
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493201
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID259331
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID859478
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID37238
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID450745
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9606
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505924
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9VV43
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ7TQD2
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100689061
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ27957
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID840
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID526279
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ03181
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID549448
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID456201
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA0A287AGZ2
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID64026
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501844
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID43514
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35396
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID39130
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID9626710
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5311128
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF1MD58
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCD3ZQL7
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID9616835
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID40848
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID37888
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID41124
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF7E6A3
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25402
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11683
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100766857
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID42008
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID10376
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID33501
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419486648
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID50528
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID408016
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID423901
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID8626312
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID43359
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID12367
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9606
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID395476
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID12369

Total number of triples: 89.